Cargando…
SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc (1) inhibitors
A previous phenotypic screen by GSK identified 2-(quinolin-4-yloxy)acetamides as potent growth inhibitors of Mycobacterium tuberculosis (Mtb). We report the results of a preliminary structure–activity relationship (SAR) study of the compound class which has yielded more potent inhibitors. An Mtb cyt...
Autores principales: | Phummarin, Narisa, Boshoff, Helena I., Tsang, Patricia S., Dalton, James, Wiles, Siouxsie, Barry 3rd, Clifton E., Copp, Brent R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292992/ https://www.ncbi.nlm.nih.gov/pubmed/28337336 http://dx.doi.org/10.1039/c6md00236f |
Ejemplares similares
-
Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms
por: Dalton, James P., et al.
Publicado: (2016) -
Bis[N-benzyl-2-(quinolin-8-yloxy)acetamide] monohydrate
por: Wang, Ming-Shi, et al.
Publicado: (2011) -
N-Methyl-N-phenyl-2-(quinolin-8-yloxy)acetamide monohydrate
por: Zhi, Li-Hua, et al.
Publicado: (2011) -
Aqua[N-phenyl-2-(quinolin-8-yloxy)acetamide]dinitratozinc(II)
por: Wu, Wei-Na, et al.
Publicado: (2010) -
Bis[N-benzyl-2-(quinolin-8-yloxy)acetamide]dichloridocopper(II) acetonitrile solvate monohydrate
por: Wang, Yuan, et al.
Publicado: (2010)